According to Techub News, the Hong Kong Stock Exchange's official information disclosure system showed that on July 17, HT Medical (01931.HK) issued an announcement, officially launching the "IVDNewCo Exchange" ecosystem plan, introducing the world's first RWA exchange ecosystem focused on medical innovative drug NewCo high-tech assets and accompanying IVDD stablecoin issuance plan.
The company is actively promoting a milestone strategic initiative to build an "NewCo + RWA + Web3" exchange ecosystem centered on medical innovative drug high-tech assets, which will be named "IVDNewCo Exchange", and will be accompanied by the issuance of a proprietary stablecoin (IVDDollar "IVDD").
This strategy aims to disrupt traditional pharmaceutical industry development rules by integrating Web3 technologies (including RWA real-world asset tokenization, blockchain trading, and stablecoin mechanisms), enhancing the liquidity, financing efficiency, and accessibility of global medical innovative drug assets. The following will elaborate on the ecosystem's strategic concept, progress, inherent advantages, and future plans.
https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0717/2025071701217_c.pdf
